Rezulin: Diabetes Drug

RezulinŽ Online is an Internet resource designed to help people who may suffer from liver damage due the use of the diabetes drug Rezulin. Look to this site for the newest research, diagnosis information, legal resources and treatment options for patients who have used Rezulin.

Are you...

  • Experiencing signs of liver damage due to the use of the prescription drug Rezulin?
  • Wondering where to turn now that Rezulin has been removed from the market?
  • Concerned that no one is protecting your rights?

If you answered "yes" to any of these questions, it's important that you explore this site further and find out more about your options.

Rezulin News Timeline

1997
January - Rezulin is approved by the FDA to treat Type II diabetes.
November - The FDA issues a warning about Rezulin (troglitazone). Recommended prescribing information is changed by the drug's manufacturer; new warning label information is added.
December - Approximately 150 adverse events associated with Rezulin have been reported to the FDA.
1998
June - The FDA and Rezulin manufacturer Parke-Davis agree to again tighten restrictions on the use of Rezulin.
July - Parke-Davis sends a letter to heathcare professionals warning to test for liver abnormalities and updating them on the changes in recommended use.
2001
March - Resulin sales are discontinued.

Contact Us

Questions? Comments? Need Legal help? Contact us today.

Contact Information



Diagnosis

Have you been diagnosed with an rezulin-related disease or injury?:

  • No
  • Yes

If you answered yes, what rezulin-related injury have you been diagnosed with?:

Your Comments:

(Required fields are marked with an *.)

Last Updated: May 11, 2010. 11:09:29 am.